MENLO PARK, Calif. — Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, today announced $40 million in venture debt financing from Oxford...
ByThe RegistryJune 23, 2022
Signup for news and special announcements!
You have successfully joined our subscriber list.